Bovine growth hormone-transgenic mice have major alterations in hepatic expression of metabolic genes

American Journal of Physiology - Endocrinology and Metabolism

Volumn 285, Issue 3 48-3, 2003, Pages

  Olsson, Bob ^a,b   Bohlooly Y, Mohammad ^a,b   Brusehed, Ola ^a,b   Isaksson, Olle G P ^b   Ahrén, Bo ^e   Olofsson, Sven Olof ^a,c   Oscarsson, Jan ^a,c   Törnell, Jan ^a,d  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d ASTRAZENECA R AND D   (Sweden)

^e LUND UNIVERSITY   (Sweden)

Author keywords

DNA microarray; Fatty acids; Peroxisome proliferator activated receptor sterol regulatory element binding protein; Transgenic mice

Indexed keywords

APOLIPOPROTEIN B; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; KETONE BODY; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN;

ANIMAL TISSUE; ARTICLE; BODY MASS; CONTROLLED STUDY; DNA MICROARRAY; FATTY ACID OXIDATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GLUCOSE TOLERANCE; HEART FUNCTION; INSULIN RESISTANCE; LIPOPROTEIN METABOLISM; LIVER PARENCHYMA; MALE; METABOLIC REGULATION; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0041965899     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00444.2002     Document Type: Article

References (71)

1. Alexander L, Appleton D, Hall R, Ross WM, and Wilkinson R. Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol (Oxf) 12: 71-79, 1980.
2. Angelin B and Rudling M. Growth hormone and hepatic lipoprotein metabolism. Curr Opin Lipidol 5: 160-165, 1994.
3. Bengtsson BA, Brummer RJ, Eden S, and Bosaeus I. Body composition in acromegaly. Clin Endocrinol (Oxf) 30: 121-130, 1989.
4. Bohlooly YM, Olsson B, Gritli-Linde A, Brusehed O, Isaksson OG, Ohlsson C, Soderpalm B, Tornell J, and Ola B. Enhanced spontaneous locomotor activity in bovine GH transgenic mice involves peripheral mechanisms. Endocrinology 142: 4560-4567, 2001.
5. Bollano E, Omerovic E, Bohlooly-y M, Kujacic V, Madhu B, Tornell J, Isaksson O, Soussi B, Schulze W, Fu ML, Matejka G, Waagstein F, and Isgaard J. Impairment of cardiac function and bioenergetics in adult transgenic mice overexpressing the bovine growth hormone gene. Endocrinology 141: 2229-2235, 2000.
6. Brem G, Wanke R, Wolf E, Buchmuller T, Muller M, Brenig B, and Hermanns W. Multiple consequences of human growth hormone expression in transgenic mice. Mol Biol Med 6: 531-547, 1989.
7. Carlsson L, Linden D, Jalouli M, and Oscarsson J. Effects of fatty acids and growth hormone on liver fatty acid-binding protein and PPARα in rat liver. Am J Physiol Endocrinol Metab 281: E772-E781, 2001.
8. Cases S, Stone SJ, Zhou P, Yen E, Tow B, Lardizabal KD, Voelker T, and Farese RV Jr. Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members. J Biol Chem 276: 38870-38876, 2001.
9. Cecim M, Ghosh PK, Esquifino AI, Began T, Wagner TE, Yun JS, and Bartke A. Elevated corticosterone levels in transgenic mice expressing human or bovine growth hormone genes. Neuroendocrinology 53: 313-316, 1991.
10. Davidson MB. Effect of growth hormone on carbohydrate and lipid metabolism. Endocr Rev 8: 115-131, 1987.
11. Dominici FP, Cifone D, Bartke A, and Turyn D. Alterations in the early steps of the insulin-signaling system in skeletal muscle of GH-transgenic mice. Am J Physiol Endocrinol Metab 277: E447-E454, 1999.
12. Dominici FP, Cifone D, Bartke A, and Turyn D. Loss of sensitivity to insulin at early events of the insulin signaling pathway in the liver of growth hormone-transgenic mice. J Endocrinol 161: 383-392, 1999.
13. Eisen EJ, Peterson CB, Parker IJ, and Murray JD. Effects of zinc ion concentration on growth, fat content and reproduction in oMT1a-oGH transgenic mice. Growth Dev Aging 62: 173-186, 1998.
14. Elam MB, Wilcox HG, Solomon SS, and Heimberg M. In vivo growth hormone treatment stimulates secretion of very low density lipoprotein by the isolated perfused rat liver. Endocrinology 131: 2717-2722, 1992.
15. Ericsson J, Jackson SM, Kim JB, Spiegelman BM, and Edwards PA. Identification of glycerol-3-phosphate acyltransferase as an adipocyte determination and differentiation factor 1- and sterol regulatory element-binding protein-responsive gene. J Biol Chem 272: 7298-7305, 1997.
16. Flores-Morales A, Stahlberg N, Tollet-Egnell P, Lundeberg J, Malek RL, Quackenbush J, Lee NH, and Norstedt G. Microarray analysis of the in vivo effects of hypophysectomy and growth hormone treatment on gene expression in the rat. Endocrinology 142: 3163-3176, 2001.
17. Foretz M, Guichard C, Ferre P, and Foufelle F. Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc Natl Acad Sci USA 96: 12737-12742, 1999.
18. Foretz M, Pacot C, Dugail I, Lemarchand P, Guichard C, Le Liepvre X, Berthelier-Lubrano C, Spiegelman B, Kim JB, Ferre P, and Foufelle F. ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose. Mol Cell Biol 19: 3760-3768, 1999.
19. Foss MC, Saad MJ, Paccola GM, Paula FJ, Piccinato CE, and Moreira AC. Peripheral glucose metabolism in acromegaly. J Clin Endocrinol Metab 72: 1048-1053, 1991.
20. Frick F, Bohlooly-Y M, Linden D, Olsson B, Tornell J, Eden S, and Oscarsson J. Long-term growth hormone excess induces marked alterations in lipoprotein metabolism in mice. Am J Physiol Endocrinol Metab 281: E1230-E1239, 2001.
21. Gulick T, Cresci S, Caira T, Moore DD, and Kelly DP. The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc Natl Acad Sci USA 91: 11012-11016, 1994.
22. Hamel FG, Bennett RG, Upward JL, and Duckworth WC. Insulin inhibits peroxisomal fatty acid oxidation in isolated rat hepatocytes. Endocrinology 142: 2702-2706, 2001.
23. Horton JD, Bashmakov Y, Shimomura I, and Shimano H. Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice. Proc Natl Acad Sci USA 95: 5987-5992, 1998.
24. Horton JD and Shimomura I. Sterol regulatory element-binding proteins: activators of cholesterol and fatty acid biosynthesis. Curr Opin Lipidol 10: 143-150, 1999.
25. Imai Y, Morita H, Kurihara H, Sugiyama T, Kato N, Ebihara A, Hamada C, Kurihara Y, Shindo T, Oh-hashi Y, and Yazaki Y. Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases. Atherosclerosis 149: 435-442, 2000.
26. Johnson D, al-Shawi R, and Bishop JO. Sexual dimorphism and growth hormone induction of murine pheromone-binding proteins. J Mol Endocrinol 14: 21-34, 1995.
27. Keeney DS, Murry BA, Bartke A, Wagner TE, and Mason JI. Growth hormone transgenes regulate the expression of sex-specific isoforms of 3 beta-hydroxysteroid dehydrogenase/delta 5→4-isomerase in mouse liver and gonads. Endocrinology 133: 1131-1138, 1993.
28. Keller H, Dreyer C, Medin J, Mahfoudi A, Ozato K, and Wahli W. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc Natl Acad Sci USA 90: 2160-2164, 1993.
29. Kopchick JJ, Bellush LL, and Coschigano KT. Transgenic models of growth hormone action. Annu Rev Nutr 19: 437-461, 1999.
30. Lemberger T, Staels B, Saladin R, Desvergne B, Auwerx J, and Wahli W. Regulation of the peroxisome proliferator-activated receptor alpha gene by glucocorticoids. J Biol Chem 269: 24527-24530, 1994.
31. Lopez D and McLean MP. Sterol regulatory element-binding protein-1a binds to cis elements in the promoter of the rat high density lipoprotein receptor SR-BI gene. Endocrinology 140: 5669-5681, 1999.
32. Magana MM and Osborne TF. Two tandem binding sites for sterol regulatory element binding proteins are required for sterol regulation of fatty-acid synthase promoter. J Biol Chem 271: 32689-32694, 1996.
33. Mater MK, Thelen AP, Pan DA, and Jump DB. Sterol response element-binding protein 1c (SREBP1c) is involved in the polyunsaturated fatty acid suppression of hepatic S14 gene transcription. J Biol Chem 274: 32725-32732, 1999.
34. Mathews LS, Enberg B, and Norstedt G. Regulation of rat growth hormone receptor gene expression. J Biol Chem 264: 9905-9910, 1989.
35. Mathews LS, Norstedt G, and Palmiter RD. Regulation of insulin-like growth factor I gene expression by growth hormone. Proc Natl Acad Sci USA 83: 9343-9347, 1986.
36. Miller CW and Ntambi JM. Peroxisome proliferators induce mouse liver stearoyl-CoA desaturase 1 gene expression. Proc Natl Acad Sci USA 93: 9443-9448, 1996.
37. Moennig G, Wiebusch H, Enbergs A, Dorszewski A, Dorszewski A, Kerber S, Schulte H, Vielhauer C, Haverkamp W, Assmann G, Breithardt G, and Funke H. Detection of missense mutations in the genes for lipoprotein lipase and hepatic triglyceride lipase in patients with dyslipidemia undergoing coronary angiography. Atherosclerosis 149: 395-401, 2000.
38. Morgan ET, MacGeoch C, and Gustafsson JA. Hormonal and developmental regulation of expression of the hepatic microsomal steroid 16 alpha-hydroxylase cytochrome P-450 apoprotein in the rat. J Biol Chem 260: 11895-11898, 1985.
39. Nikkila EA and Pelkonen R. Serum lipids in acromegaly. Metabolism 24: 829-838, 1975.
40. Orian JM, Snibson K, Stevenson JL, Brandon MR, and Herington AC. Elevation of growth hormone (GH) and prolactin receptors in transgenic mice expressing ovine GH. Endocrinology 128: 1238-1246, 1991.
41. Oscarsson J, Olofsson SO, Bondjers G, and Eden S. Differential effects of continuous versus intermittent administration of growth hormone to hypophysectomized female rats on serum lipoproteins and their apoproteins. Endocrinology 125: 1638-1649, 1989.
42. Oscarsson J, Ottosson M, Johansson JO, Wiklund O, Marin P, Bjorntorp P, and Bengtsson BA. Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults. II. Effects on serum lipoproteins and lipoprotein and hepatic lipase activity. Metabolism 45: 370-377, 1996.
43. Oscarsson J, Ottosson M, Vikman-Adolfsson K, Frick F, Enerback S, Lithell H, and Eden S. GH but not IGF-I or insulin increases lipoprotein lipase activity in muscle tissues of hypophysectomised rats. J Endocrinol 160: 247-255, 1999.
44. Oscarsson J, Wiklund O, Jakobsson KE, Petruson B, and Bengtsson BA. Serum lipoproteins in acromegaly before and 6-15 months after transsphenoidal adenomectomy. Clin Endocrinol (Oxf) 41: 603-608, 1994.
45. Pomp D, Oberbauer AM, and Murray JD. Development of obesity following inactivation of a growth hormone transgene in mice. Transgenic Res 5: 13-23, 1996.
46. Quaife CJ, Mathews LS, Pinkert CA, Hammer RE, Brinster RL, and Palmiter RD. Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice. Endocrinology 124: 40-48, 1989.
47. Robertson JA, Haldosen LA, Wood TJ, Steed MK, and Gustafsson JA. Growth hormone pretranslationally regulates the sexually dimorphic expression of the prolactin receptor gene in rat liver. Mol Endocrinol 4: 1235-1239, 1990.
48. Rodriguez JC, Gil-Gomez G, Hegardt FG, and Haro D. Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids. J Biol Chem 269: 18767-18772, 1994.
49. Rudling M, Parini P, and Angelin B. Effects of growth hormone on hepatic cholesterol metabolism. Lessons from studies in rats and humans. Growth Horm IGF Res 9, Suppl A: 1-7, 1999.
50. Sandstedt J, Ohlsson C, Norjavaara E, Nilsson J, and Tornell J. Disproportional bone growth and reduced weight gain in gonadectomized male bovine growth hormone transgenic and normal mice. Endocrinology 135: 2574-2580, 1994.
51. Sato R, Okamoto A, Inoue J, Miyamoto W, Sakai Y, Emoto N, Shimano H, and Maeda M. Transcriptional regulation of the ATP citrate-lyase gene by sterol regulatory element-binding proteins. J Biol Chem 275: 12497-12502, 2000.
52. Schoonjans K, Watanabe M, Suzuki H, Mahfoudi A, Krey G, Wahli W, Grimaldi P, Staels B, Yamamoto T, and Auwerx J. Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter. J Biol Chem 270: 19269-19276, 1995.
53. Shih DM, Xia YR, Wang XP, Miller E, Castellani LW, Subbanagounder G, Cheroutre H, Faull KF, Berliner JA, Witztum JL, and Lusis AJ. Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis. J Biol Chem 275: 17527-17535, 2000.
54. Shimano H. Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Prog Lipid Res 40: 439-452, 2001.
55. Shimomura I, Bashmakov Y, Ikemoto S, Horton JD, Brown MS, and Goldstein JL. Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proc Natl Acad Sci USA 96: 13656-13661, 1999.
56. Shimomura I, Matsuda M, Hammer RE, Bashmakov Y, Brown MS, and Goldstein JL. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol Cell 6: 77-86, 2000.
57. Shimomura I, Shimano H, Korn BS, Bashmakov Y, and Horton JD. Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver. J Biol Chem 273: 35299-35306, 1998.
58. Sjoberg A, Oscarsson J, Boren J, Eden S, and Olofsson SO. Mode of growth hormone administration influences triacylglycerol synthesis and assembly of apolipoprotein B-containing lipoproteins in cultured rat hepatocytes. J Lipid Res 37: 275-289, 1996.
59. Smith SJ, Cases S, Jensen DR, Chen HC, Sande E, Tow B, Sanan DA, Raber J, Eckel RH, and Farese RV Jr. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat. Nat Genet 25: 87-90, 2000.
60. Soderpalm B, Ericson M, Bohlooly M, Engel JA, and Tornell J. Bovine growth hormone transgenic mice display alterations in locomotor activity and brain monoamine neurochemistry. Endocrinology 140: 5619-5625, 1999.
61. Stefanadis C, Diamantopoulos L, Dernellis J, Economou E, Tsiamis E, Toutouzas K, Vlachopoulos C, and Toutouzas P. Heat production of atherosclerotic plaques and inflammation assessed by the acute phase proteins in acute coronary syndromes. J Mol Cell Cardiol 32: 43-52, 2000.
62. Thompson BJ, Shang CA, and Waters MJ. Identification of genes induced by growth hormone in rat liver using cDNA arrays. Endocrinology 141: 4321-4324, 2000.
63. Tollet-Egnell P, Flores-Morales A, Odeberg J, Lundeberg J, and Norstedt G. Differential cloning of growth hormone-regulated hepatic transcripts in the aged rat. Endocrinology 141: 910-921, 2000.
64. Tollet-Egnell P, Flores-Morales A, Stahlberg N, Malek RL, Lee N, and Norstedt G. Gene expression profile of the aging process in rat liver: normalizing effects of growth hormone replacement. Mol Endocrinol 15: 308-318, 2001.
65. Trigatti B, Rayburn H, Vinals M, Braun A, Miettinen H, Penman M, Hertz M, Schrenzel M, Amigo L, Rigotti A, and Krieger M. Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc Natl Acad Sci USA 96: 9322-9327, 1999.
66. Varanasi U, Chu R, Huang Q, Castellon R, Yeldandi AV, and Reddy JK. Identification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl coenzyme A oxidase gene. J Biol Chem 271: 2147-2155, 1996.
67. Wolf E, Wanke R, Schenck E, Hermanns W, and Brem G. Effects of growth hormone overproduction on grip strength of transgenic mice. Eur J Endocrinol 133: 735-740, 1995.
68. Yamada J, Sugiyama H, Tamura H, and Suga T. Hormonal modulation of peroxisomal enzyme induction caused by peroxisome proliferators: suppression by growth and thyroid hormones in cultured rat hepatocytes. Arch Biochem Biophys 315: 555-557, 1994.
69. Yamada J, Sugiyama H, Watanabe T, and Suga T. Suppressive effect of growth hormone on the expression of peroxisome proliferator-activated receptor in cultured rat hepatocytes. Res Commun Mol Pathol Pharmacol 90: 173-176, 1995.
70. Yoon JB, Towle HC, and Seelig S. Growth hormone induces two mRNA species of the serine protease inhibitor gene family in rat liver. J Biol Chem 262: 4284-4289, 1987.
71. Zambon A, Hokanson JE, Brown BG, and Brunzell JD. Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density. Circulation 99: 1959-1964, 1999.